Recent Updates
Recently added Catalysts
ACB Positive Sentiment Score: 70/100

Aurora Cannabis to Host Second Quarter 2026 Investor Conference Call NASDAQ | TSX

Key Takeaway: Aurora Cannabis Inc. has announced a conference call to discuss its financial results for the second quarter of 2026, scheduled for November 5, 2025. The announcement highlights the company's focus on transparency and engagement with investors. Executive Chairman Miguel Martin and CFO Simona King will lead the call. The event follows the release of the company's financial results prior to market opening on the same day, reflecting Aurora's commitment to keeping shareholders informed.

Market Sentiment Analysis

POSITIVE FACTORS

  • Scheduled conference call indicates transparency with investors.
  • Aurora Cannabis showcases its commitment to growth through regular updates.
  • Financial results are anticipated, which could reflect positive business performance.

Full Press Release Details

Aurora Cannabis to Host Second Quarter 2026 Investor
EDMONTON, AB, Oct. 22, 2025 /CNW/ - Aurora Cannabis
Inc. (the "Company" or "Aurora") (NASDAQ: ACB) (TSX: ACB), the Canadian based leading global medical cannabis company,
announced today that it has scheduled a conference call to discuss the results for its second quarter 2026 on Wednesday, November 5, 2025
at 8:00 a.m. Eastern Time | 6:00 a.m. Mountain Time. The Company will report its financial results for the second quarter 2026 before
the opening of markets that same day.
Conference Call Details
DATE: Wednesday, November 5, 2025
TIME: 8:00 a.m. Eastern Time | 6:00 a.m. Mountain Time
WEBCAST: Click Here
Miguel Martin, Executive Chairman and Chief Executive
Officer, and Simona King, Chief Financial Officer, will host the conference call and question and answer period. This weblink has also
been posted to the Company's "Investor Info" link at https://www.auroramj.com/investors/ under "Events".
About Aurora Cannabis
Aurora is opening the world to cannabis, serving both
the medical and consumer markets across Canada, Europe, Australia and New Zealand. Headquartered in Edmonton, Alberta, Aurora is a pioneer
in global cannabis, dedicated to helping people improve their lives. The Company's adult- use brand portfolio includes Drift, San
Rafael '71, Daily Special, Tasty's, Being and Greybeard. Medical cannabis brands include MedReleaf, CanniMed, Aurora and Whistler Medical
Marijuana Co, as well as international brands, Pedanios, IndiMed and CraftPlant. Aurora also has a controlling interest in Bevo Farms
Ltd., North America's leading supplier of propagated agricultural plants. Driven by science and innovation, and with a focus on high-quality
cannabis products, Aurora's brands continue to break through as industry leaders in the medical, wellness and adult recreational markets
Aurora's common shares trade on the NASDAQ and TSX
under the symbol "ACB".
Forward Looking Information
This news release includes statements containing certain
"forward-looking information" within the meaning of applicable securities law ("forward-looking statements"). Forward-looking
statements are frequently characterized by words such as "plan", "continue", "expect", "project",
"intend", "believe", "anticipate", "estimate", "may", "will", "potential",
"proposed" and other similar words, or statements that certain events or conditions "may" or "will" occur.
Forward-looking statements made in this news release include, but are not limited to, statements regarding the timing for the release
of the Company's fiscal 2026 Q2 financial statements and the conference call to discuss the results.
These forward-looking statements are only predictions.
Forward looking information or statements contained in this news release have been developed based on assumptions management considers
to be reasonable. Material factors or assumptions involved in developing forward-looking statements include, without limitation, publicly
available information from governmental sources as well as from market research and industry analysis and on assumptions based on data
and knowledge of this industry which the Company believes to be reasonable. Forward-looking statements are subject to a variety of risks,
uncertainties and other factors that management believes to be relevant and reasonable in the circumstances could cause actual events,
results, level of activity, performance, prospects, opportunities or achievements to differ materially from those projected in the forward-looking
statements. These risks include, but are not limited to, the magnitude and duration of potential new or increased tariffs imposed on goods
imported from Canada into the United States; the ability to retain key personnel, the ability to continue investing in infrastructure
to support growth, the ability to obtain financing on acceptable terms, the continued quality of our products, customer experience and
retention, the development of third party government and non-government consumer sales channels, management's estimates of consumer demand
in Canada and in jurisdictions where the Company exports, expectations of future results and expenses, the risk of successful integration
of acquired business and operations, management's estimation that SG&A will grow only in proportion of revenue growth, the ability
to expand and maintain distribution capabilities, the impact of competition, the general impact of financial market conditions, the yield
from cannabis growing operations, product demand, changes in prices of required commodities, competition, and the possibility for changes
in laws, rules, and regulations in the industry, epidemics, pandemics or other public health crises and other risks, uncertainties and
factors set out under the heading "Risk Factors" in the Company's annual information from dated June 17, 2025 (the "AIF")
and filed with Canadian securities regulators available on the Company's issuer profile on SEDAR+ at www.sedarplus.com and filed
with and available on the SEC's website at www.sec.gov. The Company cautions that the list of risks, uncertainties and other factors described
in the AIF is not exhaustive and other factors could also adversely affect its results. Readers are urged to consider the risks, uncertainties
and assumptions carefully in evaluating the forward-looking statements and are cautioned not to place undue reliance on such information.
The Company is under no obligation, and expressly disclaims any intention or obligation, to update or revise any forward-looking statements,
whether as a result of new information, future events or otherwise, except as expressly required by applicable securities law.
SOURCE Aurora Cannabis Inc.
View original content to download multimedia: http://www.newswire.ca/en/releases/archive/October2025/22/c6587.html
For further information: For Media: Michelle Lefler, VP, Communications
& PR, media@auroramj.com; For Investors: ICR, Inc., Investor Relations aurora@icrinc.com
CO: Aurora Cannabis Inc.
CNW 17:15e 22-OCT-25

Frequently Asked Questions

When is Aurora Cannabis' Q2 2026 earnings call scheduled?

The earnings call is on November 5, 2025, at 8:00 a.m. Eastern Time.

Who will host the Aurora Cannabis earnings call?

Miguel Martin and Simona King will host the conference call.

Where can I find more information about Aurora Cannabis?

Visit the Investor Info section on Aurora's website for details.

What is Aurora Cannabis known for?

Aurora is a leader in medical cannabis for both consumer and medical markets.

What stock exchanges list Aurora Cannabis shares?

Aurora's shares trade on NASDAQ and TSX under the symbol 'ACB'.

Last updated: Oct 22, 2025